Q&A

Bioprocess Development For Biosimilar Production

Eppendorf
PIM ID 590688

Establishing robust upstream bioprocesses and scaling them up to larger volumes are critical steps in biosimilar development. In this interview we talked with Yunsun Song and Barry Crowley from the Process Technology and Innovation team at Alvotech®. Read thier insights on which process parameters are key to ensure consistent product quality and how automation can make the scientists’ lives easier.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online